Table 5.
Reimbursement | Croatia and EU Member States |
---|---|
Reimbursement lists: | |
positive list(s) |
AT, BE, BG, CY, CZ, DK, EE, FI, FR, HR, HU, IE, IT, LT, LU, LV, MT, NL, PL, PT, RO, SE, SI, SK |
negative list(s) |
DE, EL†, ES, HU, UK |
Reimbursement rates: | |
only 100% |
AT, DE, IE, IT, MT, NL, UK |
100% and further rates |
BE, BG, CY, CZ‡, DK, EE, EL, ES, FI, FR, HR, HU, LT, LU, LV, PL, PT, RO, SE, SI, SK |
Co-payments/out-of-pocket payments (multiple types of co-payments possible): | |
fixed fee (eg, prescription fee) |
AT, DK, EE, FI, FR, HR, HU, IT§, PL, SK, UK |
percentage co-payment |
BE, BG, CY, CZ, DE║, DK¶, EE, EL, ES, FI, FR, HR, HU, LT, LU, LV, PL, PT, RO, SE¶, SI, SK |
other out-of-pocket payments | IE**, MT†† |
*Source: Survey by the authors, information provided by members of the Pharmaceutical Pricing and Reimbursement Information network. Country abbreviations are explained in the Table 1.
†There is a legal basis, but the negative list has not been implemented yet. Currently, the re-introduction of positive list is ongoing.
‡No fixed rates defined except for bacterial/immune stimulants.
§In some regions.
║It is a prescription fee of 10% of the medicine’s price (with absolute minimum and maximum).
¶Depending on pharmaceutical expenses of the patient.
**Out-of pocket payments after a certain threshold of pharmaceutical expenses under a specific reimbursement scheme.
††In the private sector.